| HIV therapy by a combination of broadly neutralizing antibodies in humanized mice F Klein, A Halper-Stromberg, JA Horwitz, H Gruell, JF Scheid, ... Nature 492 (7427), 118-122, 2012 | 576 | 2012 |
| A genetically humanized mouse model for hepatitis C virus infection M Dorner, JA Horwitz, JB Robbins, WT Barry, Q Feng, K Mu, CT Jones, ... Nature 474 (7350), 208-211, 2011 | 442 | 2011 |
| Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus E Giang, M Dorner, JC Prentoe, M Dreux, MJ Evans, J Bukh, CM Rice, ... Proceedings of the National Academy of Sciences 109 (16), 6205-6210, 2012 | 362 | 2012 |
| Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD … E Billerbeck, WT Barry, K Mu, M Dorner, CM Rice, A Ploss Blood, The Journal of the American Society of Hematology 117 (11), 3076-3086, 2011 | 313 | 2011 |
| HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice JA Horwitz, A Halper-Stromberg, H Mouquet, AD Gitlin, A Tretiakova, ... Proceedings of the National Academy of Sciences 110 (41), 16538-16543, 2013 | 292 | 2013 |
| Completion of the entire hepatitis C virus life cycle in genetically humanized mice M Dorner, JA Horwitz, BM Donovan, RN Labitt, WC Budell, T Friling, ... Nature 501 (7466), 237-241, 2013 | 261 | 2013 |
| Broadly neutralizing antibodies abrogate established hepatitis C virus infection YP De Jong, M Dorner, MC Mommersteeg, JW Xiao, AB Balazs, ... Science translational medicine 6 (254), 254ra129-254ra129, 2014 | 237 | 2014 |
| 3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection AM Ortega-Prieto, JK Skelton, SN Wai, E Large, M Lussignol, ... Nature communications 9 (1), 682, 2018 | 210 | 2018 |
| Dengue reporter viruses reveal viral dynamics in interferon receptor-deficient mice and sensitivity to interferon effectors in vitro JW Schoggins, M Dorner, M Feulner, N Imanaka, MY Murphy, A Ploss, ... Proceedings of the National Academy of Sciences 109 (36), 14610-14615, 2012 | 190 | 2012 |
| Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection P Guermonprez, J Helft, C Claser, S Deroubaix, H Karanje, A Gazumyan, ... Nature medicine 19 (6), 730-738, 2013 | 168 | 2013 |
| Plasma cell toll‐like receptor (TLR) expression differs from that of B cells, and plasma cell TLR triggering enhances immunoglobulin production M Dorner, S Brandt, M Tinguely, F Zucol, JP Bourquin, L Zauner, C Berger, ... Immunology 128 (4), 573-579, 2009 | 134 | 2009 |
| Animal models for hepatitis C E Billerbeck, Y De Jong, M Dorner, C De La Fuente, A Ploss Hepatitis C virus: from molecular virology to antiviral therapy, 49-86, 2013 | 109 | 2013 |
| Interferon lambda alleles predict innate antiviral immune responses and hepatitis C virus permissiveness T Sheahan, N Imanaka, S Marukian, M Dorner, P Liu, A Ploss, CM Rice Cell host & microbe 15 (2), 190-202, 2014 | 105 | 2014 |
| Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission MT Catanese, J Loureiro, CT Jones, M Dorner, T von Hahn, CM Rice Journal of virology 87 (15), 8282-8293, 2013 | 100 | 2013 |
| Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells E Billerbeck, MC Mommersteeg, A Shlomai, JW Xiao, L Andrus, A Bhatta, ... Journal of hepatology 65 (2), 334-343, 2016 | 86 | 2016 |
| Advances in experimental systems to study hepatitis C virus in vitro and in vivo MT Catanese, M Dorner Virology 479, 221-233, 2015 | 78 | 2015 |
| Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis M Lussignol, M Kopp, K Molloy, G Vizcay-Barrena, RA Fleck, M Dorner, ... Proceedings of the National Academy of Sciences 113 (9), 2484-2489, 2016 | 75 | 2016 |
| T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses CJ Reynolds, OM Suleyman, AM Ortega-Prieto, JK Skelton, ... Scientific reports 8 (1), 672, 2018 | 63 | 2018 |
| Immune evasion strategies during chronic hepatitis B and C virus infection AM Ortega-Prieto, M Dorner Vaccines 5 (3), 24, 2017 | 63 | 2017 |
| A Hitchhiker's guide to humanized mice: new pathways to studying viral infections JK Skelton, AM Ortega‐Prieto, M Dorner Immunology 154 (1), 50-61, 2018 | 61 | 2018 |
